FDA Panel to Weigh Improved Booster Shots From Moderna, Pfiz

Because the virus mutates so quickly, the FDA may approve the new vaccine formulations as COVID cases are expected to surge again this winter.

Related Keywords

New York , United States , Houston , Texas , Baylor College Of Medicine , Michigan , Philadelphia , Pennsylvania , Paul Offit , Arnold Monto , Steven Reinberg Healthday , Kelly Moore , Peter Hotez , Pfizer , New York Times , Us National Institutes Of Health , Drug Administration , University Of Michigan , Healthday News , Baylor College , John Beigel , Covid Variants , Covid 19 , Covid , Omicron Variant , Covid Vaccine , Omicron Variant Vaccine ,